Zacks Highlights Biotech Stocks: Incyte, BioMarin, Exelixis, Halozyme, Blueprint
Zacks Equity Research reviews biotech stocks poised for growth amid economic challenges Zacks Highlights Biotech Stocks: Incyte, BioMarin, Exelixis, Halozyme, Blueprint Chicago: So, Zacks Equity Research just dropped some insights on a few biotech stocks that are looking pretty good right now. They’re talking about Incyte, BioMarin, Exelixis, Halozyme, and Blueprint Medicines. With the economy…